Syros Pharmaceuticals Inc increased III. Quarter net loss per share of $-3.21 compare to net loss per share of $-0.41 recorded in the same quarter a year ago a decrease compare to $-0.54 realized in previous quarter.
III. Quarter
Earnings Per Share
Revenues
$ -3.21
$
4 Mill
$-2.80
$-2M-31.7 %
Syros Pharmaceuticals Inc 's Revenue
fell by
-31.7 % in III. Quarter (Sep 30 2022) year on year,
to $4 million and
declined by
-38 % sequentially.
Syros Pharmaceuticals Inc is Expected to report next financial results on March 14, 2023.
Syros Pharmaceuticals Inc 's
in III. Quarter recorded net loss of $-30.253 million, an increase from net loss of $-26.027 million in III. Quarter a year ago.
Sequentially
net loss narrowed from net loss of $-34.481 million realized in previous quarter.
SYRS's Cash flow
In III. Quarter company's net cash flow was $112 million, capital expenditures fell by 5.81%, to $0 millions compare to same quarter a year ago and fell by 195.50% from II. Quarter (Jun 30 2022).
